Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,747 total articles

United Community Banks, Inc. and Peach State Bancshares, Inc., The Parent of Peach State Bank & Trust, Announce Merger Agreement

United Community Banks, Inc. and Peach State Bancshares, Inc., The Parent of Peach State Bank & Trust, Announce Merger Agreement

United Community Banks, Inc. has entered a definitive agreement to acquire Peach State Bancshares, Inc. in a stock and cash transaction valued at approximately $100.8 million. The merger will combine United's strong regional banking presence with Peach State Bank & Trust's established footprint in Hall County, Georgia, enhancing market reach and cu…

Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting

Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting

Corvus Pharmaceuticals will host an investor and analyst meeting on May 14, 2026 to present new Phase 1 clinical trial data for soquelitinib, a selective ITK inhibitor, showing immunologic and biomarker evidence supporting drug-free remissions in moderate-to-severe atopic dermatitis. The data will be presented at the Society for Investigative Derma…

Anterix and Public Utility District No. 1 of Benton County Bring Private Wireless to the Pacific Northwest

Anterix and Public Utility District No. 1 of Benton County Bring Private Wireless to the Pacific Northwest

Anterix has entered into an agreement with Public Utility District No. 1 of Benton County, Washington, to sell a 10 MHz 900 MHz spectrum license, enabling Benton PUD to establish a private wireless broadband network. This deployment marks the first among publicly owned utilities in the Pacific Northwest, enhancing grid automation, workforce connect…

United Community Banks, Inc. Reports First Quarter Earnings

United Community Banks, Inc. Reports First Quarter Earnings

United Community Banks, Inc. announced net income of $84.3 million and diluted EPS of $0.69 for Q1 2026, showing significant improvement from the prior year. The bank achieved strong revenue growth, a widened net interest margin, and loan growth supported by increased customer deposits. It also declared a quarterly dividend increase, repurchased sh…

SVM Machining, Inc. Signs Long-Term Agreement to Supply Mission-Critical Aerospace and Defense Components to Turbo-Jet Products Co., Inc.

SVM Machining, Inc. Signs Long-Term Agreement to Supply Mission-Critical Aerospace and Defense Components to Turbo-Jet Products Co., Inc.

PMGC Holdings Inc.'s subsidiary, SVM Machining, Inc., has entered a long-term agreement with Turbo-Jet Products Co., Inc. to supply aerospace and defense components over an initial five-year term with annual renewal options. This agreement enhances SVM's strategic position in the aerospace and defense supply chain and compliance with government reg…

Simply Good Foods Announces Cost Savings Initiatives and Leadership Changes as Part of Ongoing Strategic Evolution

Simply Good Foods Announces Cost Savings Initiatives and Leadership Changes as Part of Ongoing Strategic Evolution

The Simply Good Foods Company announced strategic cost savings and organizational realignment initiatives, including leadership changes, aimed at simplifying the company structure, improving operational efficiency, and positioning the business for future growth within the nutritional snacking sector. These initiatives are expected to yield approxim…

Tecnoglass Sets Date for First Quarter 2026 Results

Tecnoglass Sets Date for First Quarter 2026 Results

Tecnoglass, a leading producer of aluminum and vinyl windows and architectural glass, is set to release its first quarter 2026 financial results on May 7, 2026. The company will host a webcast and conference call to discuss the results, enabling investors to gain insights into its performance.

Independent Nonclinical Research on Lasofoxifene Presented at American Association for Cancer Research Annual Meeting 2026 Consistent with LeonaBio’s Data

Independent Nonclinical Research on Lasofoxifene Presented at American Association for Cancer Research Annual Meeting 2026 Consistent with LeonaBio’s Data

LeonaBio, Inc. announced that independent nonclinical research presented at the AACR26 conference validates the potential of its drug candidate lasofoxifene as a selective estrogen receptor modulator for treating metastatic ER-positive breast cancer, particularly in patients with ESR1 mutations. The data demonstrate lasofoxifene's dual role in supp…

Guardforce AI Reports Full Year 2025 Financial Results

Guardforce AI Reports Full Year 2025 Financial Results

Guardforce AI announced its financial results for the full year 2025, showing an 8% increase in total revenue to $35.2 million, driven by growth in AI, Robotics-as-a-Service, and Smart Solutions. The company launched the AI Agent DeepVoyage Go and expanded smart retail solutions in Thailand. Despite a net loss, the loss narrowed by 10%, and negativ…

XORTX Meets Nasdaq Continued Listing Requirements

XORTX Meets Nasdaq Continued Listing Requirements

XORTX Therapeutics Inc. announced that it has regained compliance with Nasdaq's minimum bid price rule following a 1-for-5 reverse stock split that elevated its share price above the required $1.00 threshold. The company received a official letter of compliance from Nasdaq, curing the deficiency. XORTX is a late-stage clinical pharmaceutical compan…

Mobilicom Secures $2.2 Million in New Purchase Orders for U.S. DoW Program of Record with Tier-1 Drone Manufacturer

Mobilicom Secures $2.2 Million in New Purchase Orders for U.S. DoW Program of Record with Tier-1 Drone Manufacturer

Mobilicom Limited has received $2.2 million in new purchase orders from a major U.S. defense drone manufacturer as part of a $249 million Program of Record with the U.S. Department of War. These orders reflect an increase from previous engagements under the same program. Deliveries have commenced and will continue through 2026. Mobilicom's cybersec…

Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting

Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting

Rezolute, Inc., a rare disease biopharmaceutical company, announced that results from its Phase 3 sunRIZE study evaluating ersodetug in treating congenital hyperinsulinism (HI) will be presented at the Pediatric Endocrine Society Annual Meeting. The study showed promising therapeutic benefits of ersodetug, an antibody designed to reduce hypoglycemi…

BioAge Reports Positive Phase 1 Data for BGE-102, a Novel Oral NLRP3 Inhibitor, Demonstrating Potential Best-in-Class Reductions in hsCRP

BioAge Reports Positive Phase 1 Data for BGE-102, a Novel Oral NLRP3 Inhibitor, Demonstrating Potential Best-in-Class Reductions in hsCRP

BioAge Labs announced positive Phase 1 clinical trial results for BGE-102, a novel oral NLRP3 inhibitor targeting inflammation related to aging and cardiovascular risk. The drug demonstrated significant reductions in hsCRP and other inflammatory biomarkers in obese participants, with good tolerability. Based on these results, BioAge plans to initia…

Eupraxia Pharmaceuticals Reports Positive Nine-Month Tissue Health and Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis

Eupraxia Pharmaceuticals Reports Positive Nine-Month Tissue Health and Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis

Eupraxia Pharmaceuticals announced positive 36-week clinical and tissue health data from the highest dose cohort (Cohort 9) of their ongoing Phase 1b/2a RESOLVE trial of EP-104GI, a novel treatment for eosinophilic esophagitis (EoE). The highest dose cohort showed substantial improvement in tissue health and symptom remission rates with no serious …

Aeluma Receives NASA Award for Integrated Quantum Dot Lasers

Aeluma Receives NASA Award for Integrated Quantum Dot Lasers

Aeluma, Inc., a semiconductor company listed on NASDAQ, received a NASA award to accelerate development and commercialization of its integrated quantum dot laser platform. This technology aims to improve AI data center interconnects and sensing applications by integrating quantum dot lasers directly onto silicon, enhancing performance and scalabili…

Bowman to Attend May Investor Conferences

Bowman to Attend May Investor Conferences

Bowman Consulting Group Ltd., a national engineering and program management firm, announced its participation in two major investor conferences in May 2026. The company aims to engage with investors at the BofA Securities Industrials, Transportation & Airlines Key Leaders Conference and the B. Riley Securities 26th Annual Institutional Investor Con…